ConductScience.org, home

Paper36367013

Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022.

Stefanelli P and 26 others. Euro Surveill, 2022. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022. Papers, record 36367013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36367013

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022.
PubMed
Journal
Euro Surveill
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
1.96
iCite
Revised in PubMed
2026-05-18
PubMed

Authors27

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stefanelli PPaola
2Trentini FFilippo
3Petrone DDaniele
4Mammone AAlessia
5Ambrosio LLuigina
6Manica MMattia
7Guzzetta GGiorgio
8d'Andrea VValeria
9Marziano VValentina
10Zardini AAgnese
11Molina Grane' CCarla
12Ajelli MMarco
13Di Martino AAngela
14Riccardo FFlavia
15Bella AAntonino
16Sane Schepisi MMonica
17Maraglino FFrancesco
18Poletti PPiero
19Palamara ATAnna Teresa
20Brusaferro SSilvio

Source PubMed

See all 27 authorsDownload CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SARS-CoV-2Major topic
COVID-19Major topic
Humans
Vaccination
Base Sequence

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135411997Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.Trop Med Int Health2022https://conductscience.org/library/papers/35411997PubMed
235264324Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.BMJ2022https://conductscience.org/library/papers/35264324PubMed
335016199Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.Nature2022https://conductscience.org/library/papers/35016199PubMed
435514304COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022.Euro Surveill2022https://conductscience.org/library/papers/35514304PubMed
533750783Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China.Nat Commun2021https://conductscience.org/library/papers/33750783PubMed
635798890SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.Nat Microbiol2022https://conductscience.org/library/papers/35798890PubMed
735021005SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons.N Engl J Med2022https://conductscience.org/library/papers/35021005PubMed
833234640Rapid review of available evidence on the serial interval and generation time of COVID-19.BMJ Open2020https://conductscience.org/library/papers/33234640PubMed
932720639Authors' response: Estimating the generation interval for COVID-19 based on symptom onset data.Euro Surveill2020https://conductscience.org/library/papers/32720639PubMed
1037133863Evaluation of Waning of SARS-CoV-2 Vaccine-Induced Immunity: A Systematic Review and Meta-analysis.JAMA Netw Open2023https://conductscience.org/library/papers/37133863PubMed
1136524247Estimation of the incubation period and generation time of SARS-CoV-2 Alpha and Delta variants from contact tracing data.Epidemiol Infect2022https://conductscience.org/library/papers/36524247PubMed
1235623379COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England.Lancet Infect Dis2022https://conductscience.org/library/papers/35623379PubMed
1333767447Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.Nature2021https://conductscience.org/library/papers/33767447PubMed
1435215887The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0-3.3 Days Can Be Explained by Immune Evasion.Viruses2022https://conductscience.org/library/papers/35215887PubMed
1534814093The early phase of the COVID-19 epidemic in Lombardy, Italy.Epidemics2021https://conductscience.org/library/papers/34814093PubMed
1635791373Intrinsic generation time of the SARS-CoV-2 Omicron variant: An observational study of household transmission.Lancet Reg Health Eur2022https://conductscience.org/library/papers/35791373PubMed

Download CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
42082766Implications for distancing measures on in-person school and work attendance from Italian post-pandemic social contact data.Commun Med (Lond)2026https://conductscience.org/library/papers/42082766PubMed
41316388Booster dose reshapes SARS-CoV-2 RBD-specific B cell immunity in people living with HIV.J Transl Med2025https://conductscience.org/library/papers/41316388PubMed
41246331Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapies.Front Immunol2025https://conductscience.org/library/papers/41246331PubMed
40977733Reduced spike specific T-cell responses in COVID-19 vaccinated subjects undergoing SARS-CoV-2 breakthrough infection.Front Immunol2025https://conductscience.org/library/papers/40977733PubMed
40464897SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapy.Ann Hematol2025https://conductscience.org/library/papers/40464897PubMed
40332006Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster Vaccine.Int J Mol Sci2025https://conductscience.org/library/papers/40332006PubMed
40133656Comparative spatial-temporal analysis of SARS-CoV-2 lineages B.1.1.33 and BQ.1.1 Omicron variant across pandemic phases.Sci Rep2025https://conductscience.org/library/papers/40133656PubMed
40083630Pilot study: a descriptive-retrospective analysis of SARS-CoV-2 variants distribution and phylogenesis in the Phlegraean area.Front Mol Biosci2025https://conductscience.org/library/papers/40083630PubMed
39407950Impact and Effectiveness of COVID-19 Vaccines Based on Machine Learning Analysis of a Time Series: A Population-Based Study.J Clin Med2024https://conductscience.org/library/papers/39407950PubMed
39204049Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination.Vaccines (Basel)2024https://conductscience.org/library/papers/39204049PubMed
38675876Prevalence of Respiratory Viral Infections in Deceased Persons during the COVID-19 Pandemic Season 2021-2022: A Population-Based Observational Study.Viruses2024https://conductscience.org/library/papers/38675876PubMed
38675795Estimating All-Cause Deaths Averted in the First Two Years of the COVID-19 Vaccination Campaign in Italy.Vaccines (Basel)2024https://conductscience.org/library/papers/38675795PubMed
38455311A Comparison Between Omicron and Earlier COVID-19 Variants' Disease Severity in the Milan Area, Italy.Front Epidemiol2022https://conductscience.org/library/papers/38455311PubMed
38449900
General infection prevention, mitigation, and control procedures implemented in the university education during the COVID-19 pandemic to achieve classroom attendance: a successful community case study.
Front Public Health2023https://conductscience.org/library/papers/38449900PubMed
38187213Covid-19 Occupational Risk Incidence and Working Sectors Involved During the Pandemic in Italy.Saf Health Work2023https://conductscience.org/library/papers/38187213PubMed
38137955SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy.Life (Basel)2023https://conductscience.org/library/papers/38137955PubMed
38006015
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine.
Vaccines (Basel)2023https://conductscience.org/library/papers/38006015PubMed
37599801Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality.Influenza Other Respir Viruses2023https://conductscience.org/library/papers/37599801PubMed
37371134Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy.Cells2023https://conductscience.org/library/papers/37371134PubMed
37254497The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: A systematic review.Hum Vaccin Immunother2023https://conductscience.org/library/papers/37254497PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36367013

GET https://conductscience.org/api/papers/v1/36367013/authors?page=2